Why the study?
Does NT-proBNP predict sudden cardiac death in patients with hypertrophic cardiomyopathy?
Does NT-proBNP predict sudden cardiac death in patients with hypertrophic cardiomyopathy?
NT-proBNP may serve as a useful biomarker for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May aid sudden cardiac death risk stratification in hypertrophic cardiomyopathy; hypothesis-generating and requires prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: